Zoetis reported $2.65B in Cash and Equivalent for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Aerie Pharmaceuticals AERI:US $ 39.44M 17M
Align Technology ALGN:US $ 877.5M 48.62M
Bayer BAYN:GR € 3412M 2373M
Bristol Myers Squibb BMY:US $ 10750M 1619M
Charles River Laboratories CRL:US $ 200.32M 41.55M
Coherus Biosciences CHRS:US $ 275.48M 50.2M
Eli Lilly And LLY:US $ 2622.9M 163.7M
Endo International Ordinary Shares ENDP:US $ 1191.57M 221.58M
Henry Schein HSIC:US $ 108M 18M
Horizon Pharma HZNP:US $ 1892.56M 249.43M
Idexx Laboratories IDXX:US $ 114.36M 90.26M
Illumina ILMN:US $ 1289M 62M
IQVIA Holdings Inc IQV:US $ 1.43B 41M
Laboratory Of America LH:US $ 1068.8M 164.7M
Lannett LCI:US $ 106.11M 7.47M
Pacira Pharmaceuticals PCRX:US $ 122.06M 104.69M
Perrigo Ordinary Shares PRGO:US $ 485.3M 1480.2M
Phibro Animal Health PAHC:US $ 70.75M 7.36M
Quest Diagnostics DGX:US $ 790M 78M
Teva Pharmaceutical Industries TEVA:US $ 2058M 117M
Zoetis ZTS:US $ 2648M 484M